| Gene symbol | ACE2 | Synonyms | ACEH | Type of gene | protein-coding |
| Chromosome | X | Map location | Xp22.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | angiotensin converting enzyme 2 | ||||
| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC2340 |
| Trial ID | NCT04324996 |
| Disease | COVID-19 |
| Altered gene | NKG2D|ACE2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | NKG2D/ACE2 CAR-NK cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 |
| Year | 2020 |
| Country | China |
| Company sponsor | Chongqing Public Health Medical Center |
| Other ID(s) | ChongqingPublicHMC |
| Cohort 1 | |||||||||||
|
|||||||||||